Comparison of recombinant cyclooxygenase-2 to native isoforms: aspirin labeling of the active site

FEBS Lett. 1995 Sep 11;371(3):315-20. doi: 10.1016/0014-5793(95)00930-8.

Abstract

The search for isoform-specific enzyme inhibitors has been the focus of much recent research effort. Towards this goal, human recombinant cyclooxygenase-2 (EC 1.14.99.1, prostaglandin H synthase) was expressed in insect cells and purified to > 98% purity. Recombinant enzyme was characterized both by physical methods and activity measurements and shown to be fully active with kinetic properties similar to native COX-2 and COX-1. After detergent extraction, the enzyme had hydrodynamic properties indistinguishable from native bovine COX-1 and corresponded to the enzyme dimer as measured with size-exclusion chromatography. Peptide mapping via Lys-C protease identified a site of N-linked glycosylation and the aspirin covalent modification site. In the presence of heme, aspirin-specifically acetylated Ser-516. The enzyme will be suitable for biophysical studies and may lead to isoform-specific enzyme inhibitors.

Publication types

  • Comparative Study

MeSH terms

  • Amino Acid Sequence
  • Amino Acids / analysis
  • Animals
  • Aspirin / metabolism*
  • Binding Sites
  • Cattle
  • Gene Expression Regulation, Enzymologic
  • Glycosylation
  • Humans
  • Kinetics
  • Molecular Sequence Data
  • Peptide Mapping
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Prostaglandin-Endoperoxide Synthases / isolation & purification
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Recombinant Fusion Proteins / isolation & purification
  • Recombinant Fusion Proteins / metabolism
  • Serine / metabolism

Substances

  • Amino Acids
  • Recombinant Fusion Proteins
  • Serine
  • Prostaglandin-Endoperoxide Synthases
  • Aspirin